Oncological outcomes classified according to metastatic lesions in the era of molecular targeted drugs for metastatic renal cancer

Since the introduction of molecular targeted agents for the treatment of metastatic renal cell cancer (mRCC), several treatment outcomes, including those from our facilities, have been reported. However, the outcome of these drugs, classified by the metastatic organs, is not well known. The present...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Mol Clin Oncol
Main Authors: Shimizu, Yasuomi, Iguchi, Taro, Tamada, Satoshi, Yasuda, Sayaka, Kato, Minoru, Ninomiya, Noriko, Yamasaki, Takeshi, Nakatani, Tatsuya
פורמט: Artigo
שפה:Inglês
יצא לאור: D.A. Spandidos 2018
נושאים:
Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5958790/
https://ncbi.nlm.nih.gov/pubmed/29844909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1614
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים